| 10z-Hymenialdisine |
A23187 |
A23187, Free Acid |
| A23187, Mixed Calcium-Magnesium Salt |
AAG |
Actinomycin D |
| Adenophostin A |
AG 1007 |
AG 1024 |
| AG 1112 |
AG 126 |
AG 1288 |
| AG 1295 |
AG 1296 |
AG 1385 |
| AG 1433 |
AG 1478 |
AG 183 |
| AG 34 |
AG 370 |
AG 490 |
| AG 494 |
AG 527 |
AG 528 |
| AG 537 |
AG 658 |
AG 698 |
| AG 808 |
AG 82 |
AG 825 |
| AG 835 |
AG 879 |
AG 957 |
| AG 974 |
Anisomycin, Streptomyces griseolus |
Annexin V |
| Annexin V (APC Labelled), Human, Recombinant |
Annexin V (Biotin Labelled), Human, Recombinant |
Annexin V (FITC Labelled), Human, Recombinant |
| Annexin V (FITC) (human) (recombinant) |
Annexin V, Human, Recombinant |
Antimycin A |
| Aphidicolin, Nigrospora oryzaev |
Apicidin |
APO-1/Fas (Human) |
| APRIL |
Arctigenin, Arctium lappa |
Arctiin, Arctium lappa |
| Bax (2D2), Human |
Bax (6A7), Universal |
Bcl 10 (Carmen-1) |
| Bcl-2 (Human) (8C8) |
Bcl-2 (Human) (Bcl-2/100) |
Bcl-2 (Purified) |
| Bcl-w (13F9) |
Bcl-w (16H12) |
Bcl-X L/S (Purified) |
| Betulinic acid |
Bid (Human) (Rec.) |
Bid (truncated) (Human) (Rec.) |
| BIF-1 [Bax interacting factor-1] (Human) (30A882) |
Bim (Purified) |
BIM S/EL/L (14A8) |
| BimL (5E5) |
Blocking Peptide to Antiserum (Purified) to FLIP (NT) |
Blocking Peptide to Antiserum (Purified) to TRAIL-R2 |
| Blocking Peptide to Antiserum (Purified) to TRAIL-R2 (CT) |
Blocking Peptide to Antiserum (Purified) to TRAIL-R3 (Human) |
BMF (12E10) |
| BMF (9G10) |
BMF (Purified) |
Bongkrekic Acid |
| boswellic acid, Boswellia serrata |
boswellic acid, Boswellia sp. |
Brefeldin A, Eupenicillium brefeldianum |
| Calcein-AM |
Calpain Inhibitor II |
Calyculin A, Discodermia calyx |
| Camptothecin |
Caspase 2, Human, Recombinant, Active |
Caspase-1 (Human) |
| Caspase-1 ELISA Kit |
Caspase-1 Inhibitor (Aldehyde) |
Caspase-1 Inhibitor (Biotin) |
| Caspase-1 Inhibitor (Chloromethylketone) |
Caspase-1 Inhibitor (Fluoromethylketone) |
Caspase-1 Inhibitor III |
| Caspase-1 Inhibitor V |
Caspase-1 Inhibitor VI (Z-VAD-FMK) |
Caspase-1 Substrate (AFC) |
| Caspase-1 Substrate (Chromogenic) |
Caspase-1 Substrate (Fluorogenic) |
Caspase-1 Substrate (Mca) |
| Caspase-1, (Purified) |
Caspase-1, Human, Recombinant, Active |
Caspase-10 |
| Caspase-10/a (Human) (Active) (Rec.) |
Caspase-10/b (Human) (Active) (Rec.) |
Caspase-12 (IN) (Purified) |
| Caspase-12 (NT) (Purified) |
Caspase-14 |
Caspase-14 (70A1426) |
| Caspase-2 (10C6) |
Caspase-2 (11B4) |
Caspase-2 Inhibitor (Aldehyde) |
| Caspase-2 Substrate (Chromogenic) |
Caspase-2 Substrate (Fluorogenic) |
Caspase-3 (Active) (Purified) |
| Caspase-3 (Human) (31A1067) |
Caspase-3 (Human) (Active) (Rec.) |
Caspase-3 (Human) (Rec.) |
| Caspase-3 (Rat) (Active) (Rec.) |
Caspase-3 Control Peptide |
Caspase-3 Inhibitor (Aldehyde) |
| Caspase-3- Inhibitor (Biotin) |
Caspase-3 Inhibitor (Fluoromethylketone) |
Caspase-3 Processing Enzyme Inhibitor (Fluoromethylketone) |
| Caspase-3 Processing Enzyme Inhibitor I (Aldehyde) |
Caspase-3 Processing Enzyme Inhibitor II (Aldehyde) |
Caspase-3 Processing Enzyme Substrate (Fluorogenic) |
| Caspase-3 Processing Enzyme Substrate I (Chromogenic) |
Caspase-3 Processing Enzyme Substrate II (Chromogenic) |
Caspase-3 Processing Inhibitor II (Aldehyde) |
| Caspase-3 Processing Substrate I (Chromogenic) |
Caspase-3 Processing Substrate II (Chromogenic) |
Caspase-3 Substrate (AFC) |
| Caspase-3 Substrate (Chromogenic) |
Caspase-3 Substrate (Fluorogenic) |
Caspase-3, Human, Active, Recombinant |
| Caspase-4 (Human) (Active) (Rec) |
Caspase-4 Inhibitor (Aldehyde) |
Caspase-4 Substrate (AFC) |
| Caspase-4 Substrate (Chromogenic) |
Caspase-4 Substrate (Fluorogenic) |
Caspase-5 (Human) (Active) (Rec) |
| Caspase-5 (Purified) |
Caspase-6 (Human) (Active) (Rec.) |
Caspase-6 (Human) (B93-4) |
| Caspase-6 (Human) (Rec.) |
Caspase-6 Inhibitor (Aldehyde) |
Caspase-6 Inhibitor (Fluoromethylketone) |
| Caspase-6 Substrate (Chromogenic) |
Caspase-6 Substrate (Fluorogenic) |
Caspase-6, Human, Recombinant, Purified |
| Caspase-7 (Active) (Purified) |
Caspase-7 (Human) (Active) (Rec.) |
Caspase-7 (Human) (Rec.) |
| Caspase-7 (Purified) |
Caspase-7, Human Recombinant, Purified |
Caspase-8 (Human) (12F5) |
| Caspase-8 (Human) (Active) (Rec.) |
Caspase-8 (Human) (Rec.) |
Caspase-8 (Human) C15 |
| Caspase-8, Human Recombinant, Purified |
Caspase-9 (Active) (Purified) |
Caspase-9 (Human) |
| Caspase-9 (Human) (Active) (Rec.) |
Caspase-9 (Purified) |
Caspase-9 Inhibitor (Aldehyde) |
| Caspase-9 Inhibitor (Fluoromethylketone) |
Caspase-9 Substrate (Chromogenic) |
Caspase-9 Substrate (Fluorogenic) |
| Caspase-9, Human, Recombinant, Active |
Caveolin-2 |
Caveolin-2 Phospho-Ser23 |
| Caveolin-2 Phospho-Ser36 |
CH95, Caspase-3 inhibitor Non-Peptide |
Chelerythrine Chloride |
| Chromomycin A3 Streptomyces Griseus |
Ciglitazone |
Clusterin (Human) (CLI-9) |
| Colchicine |
COMP, Rat: Angiopoietin-1, Soluble, Human, Recombinant |
Cycloheximide, Streptomyces griseus |
| Cyclopamine |
Cyclothiazide |
Cytochalasin B, Helminthosporium dematioideum |
| Cytochalasin C |
Cytochalasin D, Zygusporium mansonii |
Cytochalasin E, Aspergillus clavatus |
| Cytochrome c ELISA Kit |
Cytochrome c Releasing Apoptosis Assay Kit (BioVision) |
Cytosol Fractionation Kit |
| Daidzein |
Daxx (Human) (CT) (Purified) |
Daxx (Human) (Daxx-01) |
| DETA-NONOate, NOC-18 |
Dimethylenastron |
DLC1 & DLC2 (11F7) |
| DLC1 [LC8; PIN] (10D6) |
DMAG |
DMNQ |
| DOTAP.mesylate |
Ebselen |
Epithelial Monocyteactivating Polypeptide II (EMAP II)(Human) |
| Epoxyquinone G109 (Racemic) |
ET-18-OCH3 |
Etoposide |
| FADD (DD) (12E7) |
FADD (Mouse) (DD) (7B5) |
FADD (Mouse) (DED) (7A2) |
| Fas [CD95] (Death Domain) (Human) (3D5) |
Fas [CD95] (Human) (2R2) |
Fas [CD95] (Human) (ANC 95.1/5E2) |
| Fas [CD95] (Human) (APO-1-1) |
Fas [CD95] (Human) (APO-1-3) |
Fas [CD95] (Human) (SM1/23) |
| Fas [CD95] (SM1/1) |
Fas Antigen, Extracellular Fragment (Recombinant) |
Fas Ligand (Human) (2C101) |
| Fas Ligand (Human) (5G51) |
Fas Ligand (Human) (Alf-2.la) |
Fas Ligand (Human) (Mike-1) |
| Fas Ligand (Human) (Mike-2) |
Fas Ligand (Mouse) (3C82) |
Fas Ligand (Mouse) (A11) |
| Fas Ligand (Mouse) (H11) |
Fas Ligand, Soluble (Human) (Rec.) |
Fas Ligand, Soluble (Human) (Rec.) Set |
| Fas Ligand, Soluble (Human) ELISA Kit |
Fas:Fc (Human) (Recombinant) |
FasLigand |
| FLIP (Dave-2) |
FLIP (Human) (NF6) |
FLIP (Human) cDNA Probe |
| FLIP (NT) (Purified) |
Forskolin, Coleus forskohlii |
Genistein |
| Gossypol |
Granzyme B Inhibitor, Aldehyde |
Granzyme B Substrate, Ac-IETD-AMC |
| Granzyme B Substrate, Ac-IETD-pNA |
Granzyme B Substrate, BAADT |
Granzyme B Substrate, Z-IETD-pNA |
| Granzyme B, Human, B18.1 |
Granzyme B, Human, GrB7 |
Granzyme B, Human, Purified |
| HR22C16 |
HtrA2/Omi |
Hydroxycamptothecin |
| Hydroxyecdysone |
Ionomycin, Free Acid, Streptomyces conglobatus |
IRS-1 (Y608) Peptide |
| JC-1.chloride |
JC-1.Iodide |
KN-62 |
| KN-93 |
Kuanoniamine C |
Lactacystin |
| Lactacystin ß-lactone, Synthetic |
LY-294002 |
MAZ51 |
| MC 1293 |
Melatonin |
MMP-2/MMP-9 Inhibitor |
| Nimesulide |
Noxa (Human) (114C307) |
Okadaic acid, Prorocentrum concavum, High Purity |
| Okadaic acid.Ammonium Salt, Prorocentrum concavum |
Okadaic acid.Potassium Salt, Prorocentrum concavum |
Okadaic acid.Sodium Salt, Prorocentrum concavum |
| Oligomycin A, Streptomyces diastatochromogenes. |
Oligomycin B, Streptomyces diastatochromogenes. |
Oligomycin C, Streptomyces diastatochromogenes. |
| Oligomycin, Streptomyces diastatochromogenes |
Olomoucine, High Purity |
Osteoprotegerin, Human, N-terminal |
| Osteoprotegerin: Fc, Human, Recombinant. |
Paclitaxel, Taxus brevifolia |
PD-153,035 |
| PD-98059 |
Pentoxyifylline |
Perforin (CB5.4) |
| Perforin (CE2.10) |
Perforin (Human) (d G9) |
PHAS-1 Substrate, (Recombinant) |
| Phorbol-12-myristate-13-acetate |
Phosphatidylinositol 3-Kinase SH3 Domain Binding Peptide |
Phosphatidylinositol-3,4,5-trisphosphate |
| Phosphatidylinositol-4,5,-biphosphate, Purified |
Phosphatidylserine Receptor (217) |
Phosphoinositide 3-kinase p110d (Human) |
| PI-3 Kinase, Human, Recombinant (Mouse) |
Pifithrin-a.hydrobromide |
Proteinase Inhibitor 9 (Human) (PI9-17) |
| Puromycin, Cell Culture Tested |
Puromycin, Solution, Cell Culture Tested |
Radicicol, Humicola fuscoatra |
| RANK (Human) |
RANKL |
RANKL, Soluble, Human, Rec. |
| Rapamycin, Streptomyces hygroscopicus |
Ratjadone (synthetic) |
Retinoic Acid |
| Roscovitine |
Salubrinal |
Scriptaid |
| SH-5 |
SH-6 |
Sirtinol |
| SNAP |
SPRR2 (Human) |
ssDNA (F7-26) |
| Staurosporine, Streptomyces staurosporeus |
Staurosporine, in Solution |
Streptozotocin |
| Synuclein, Human |
TES, High Purity |
Thalidomide |
| Thapsigargin |
Tie-2 Inhibitor 13 |
TNF-R1:Fc, Human Recombinant |
| TNF-R2:Fc |
TNF-a |
TNF-a, Soluble, Human, Recombinant, Cell Culture Grade, Kit |
| TNF-a, Soluble, Mouse, Recombinant, Cell Culture Grade, Kit |
TRAIL |
TRAIL (Human) (2E5) |
| TRAIL (Human) (HS501) |
TRAIL (Human) (lll6F) |
TRAIL (Human) (VI10E) |
| TRAIL Receptor-1 to -4 Set |
TRAIL Receptor-1 to-4 Flow Cytometry Set |
TRAIL, Soluble (Human) (Rec.) |
| TRAIL, Soluble (Human) (Rec.) Set |
TRAIL-R1 (CT) (Purified) |
TRAIL-R1 (Human) (HS101) |
| TRAIL-R1: Fc (Human) (Rec.) |
TRAIL-R2 (Purified) |
TRAIL-R2 ( Human) (HS201) |
| TRAIL-R2 (CT) (Purified) |
TRAIL-R2: Fc (Human) (Rec.) |
TRAIL-R3 (Human) (HS301) |
| TRAIL-R3 (Human) (LEIA) |
TRAIL-R3 (Human) (Purified) |
TRAIL-R3: Fc (Human) (Rec.) |
| TRAIL-R4 (Human) (HS402) |
TRAIL-R4: Fc (Human) (Rec.) |
Trans-24 |
| Trichodion, Trichospdriella sp. |
Trichostatin A |
Triptolide, Tripterygium wilfordii |
| Trityl-L-cysteine |
Valinomycin, Streptomyces fulvissimus |
VDM11 |
| VDM13 |
Vinblastine Sulfate |
Vincristine Sulfate |
| WP631.2HCl |
Xanthohumol, Humulus lupulus |